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Abstract
Inference in hierarchical nonlinear models needs careful consideration about targeting parameters
that have either a conditional or population-average interpretation. For the special case of mixed-
effects nonlinear sigmoidal models we propose a method for the estimation of derived parameters with
a marginal interpretation, but also maintaining the random effect structure of the nonlinear model,
by using a combination of numerical quadrature and the delta method, integrating over the random
effect distribution conditional on the estimated variance components. The difference between these
marginalized estimates, generalized nonlinear least squares estimates, and conditional estimation is
characterised by means of two representative case studies. The case studies consist of the estimation of
effective dose levels in a human toxicology study, and the relative potency estimation for two herbicides
in an agricultural field trial. Both case studies exhibit an experimental design that results in data
with at least one hierarchical level of between- and within-cluster variation. A user-friendly software
implementation is made available with the R package medrc, providing an automated framework for
mixed-effects dose-response modelling.
1 Introduction
Clustered data showing nonlinear trends have recently become routine output of experiments in agricul-
ture, biology, and toxicology (e.g., Clayton et al. (2003); Serroyen et al. (2005); Makowski and Lavielle
(2006)). For these applied disciplines parameter estimates with marginal interpretations rather than
conditional interpretations would usually be relevant as such quantities provide insights and understand-
ing of population-level behaviour in the biological systems considered. This is a very different focus as
compared to pharmacokinetics and pharmacodynamics studies where interest almost solely lies in the
conditional parameters (Davidian and Giltinan, 1995). Still, in practice conditional results derived from
nonlinear mixed-effects models seem to be used most of the time.
For non-normal clustered data the differences between marginal and conditional modelling are well-
understood (e.g., McCulloch et al. (2008); Serroyen et al. (2009); Fitzmaurice et al. (2012); Gbur et al.
(2012); Demidenko (2013); Vonesh (2012)). In particular the difference in interpretation in terms of
population-level versus conditional effects have been both clarified and debated over the last decade. It
has been argued that conditional modelling was to be preferred (Lee and Nelder, 2004), but there seems
to be pros and cons (Lee and Nelder, 2004, rejoinder). The conditional effects focus on a single subject,
e.g. reporting a dose-response relationship with a subject-specific initial response at the lowest dose level.
This initial effect might lead to a steeper curve, an earlier or later response, and a higher maximum
response level compared to the population average. If no information about a specific individual is
available to predict a response and just a general effect of a whole population of individuals is of interest,
the conditional effects will not be an efficient way to summarize the population distribution. And it has
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to be noted that conditioning on the average subject effects will not result in the expected population
response for nonlinear models.
In an attempt to bridge the gap between conditional and marginal models some authors have considered
marginalization (e.g.,Heagerty and Zeger (2000); Wang and Louis (2004); Parzen et al. (2011); Griswold
et al. (2013)). However, these authors only considered special cases of generalized linear mixed-effects
models, using non-standard distributional assumptions for the random effects or approximate attenuation
factors to address the integration over the random effects distributions.
Conditional inference requires distributional assumptions at the level of each cluster next to assumptions
on the distribution of each measurement whereas marginal inference may be carried out while completely
ignoring the hierarchical structure. The marginal approach results in regression coefficients that can
be interpreted as marginal effects but their standard errors will not fully incorporate the correlation
between observations within individuals; i.e. for generalized estimation equation models Liang and Zeger
(1986) showed that the standard errors of estimated marginal regression coefficients may be consistently
estimated, even when the assumed within-cluster correlation is incorrect. The relative efficiency of the
estimator will, however, be substantially increased by using a correctly specified correlation structure,
especially in case of highly correlated coefficients.
For clustered data with nonlinear trends the arguments in favour of conditional modelling using nonlinear
mixed-effects methodology are even more compelling than in the case for non-normal clustered data.
In the context of generalized linear mixed-effects models all parameters are defined on the same scale
introduced through the link function, which establishes the connection between the data scale and the
so-called model scale of the linear predictor (Stroup, 2014). In contrast, for nonlinear clustered data
usually several model scales are needed to accommodate all model parameters entering the nonlinear
model equation. For instance, three model scales, asymptotes, steepness, and ED50, are in use for the
four-parameter log-logistic model, which we will introduce in detail below. Random effects are ideally
suited to describe varying magnitudes of variation inherent to these different scales and different random
effects on different scales will ensure that variation is captured in terms of the scale where it is present.
It is difficult to imagine that marginal models can achieve a similar description of the variation based
on the data scale only. Moreover, as pointed out by Griswold et al. (2013) choosing a conditional
modelling approach does not rule out considering marginal interpretations of parameter estimates of
interest. Indeed, conditional modelling allows both conditional and marginal interpretations of results. It
is noteworthy that choosing a marginal modelling strategy does not provide the same flexibility as only
marginal interpretations will eventually be possible (McCulloch et al., 2008, p. 246).
Instead of the direct estimation of marginal parameters as in Heagerty and Zeger (2000), we focus on
calculating marginal predictions by means of population averages. Whereas the random effects in a
nonlinear hierarchical model can be defined on the different scales of the model parameters, estimating
nonlinear model coefficients conditional on these random effects, the main interest might lie on the
population averaged predictions. Based on the marginal predictions related marginalized parameters can
be derived.
In the present study, the marginalization approach, which was recently proposed by Gerhard et al. (2014)
for a specific nonlinear model for analysis of quantitative real-time polymerase chain reaction (QPCR)
data, is extended for arbitrary nonlinear mixed-effects regression models, i.e., allowing for arbitrary
random effects structures and also correlated residual errors. This extension leads a novel and operational
combination of numerical integration based on Gaussian quadrature and the delta method for error
propagation.
We will focus on important applications in pharmacology and toxicology where dose-response models
play a prominent role in evaluation of toxicity of chemicals. Such assessments usually involve one or more
quantities derived from the model parameters, e.g., effective doses that correspond to a 10%, 20%, and
50% reduction in toxicity (ED10, ED20, and ED50). These parameters are interpreted by toxicologists
naturally in a population context (e.g., Weimer et al., 2012) but unfortunately the estimates that are
currently available when fitting hierarchical models do not allow for such an interpretation. Hence, there
is an urgent need for a flexible marginalization approach that is adapted to the more complex hierarchical
designs that now also becoming more common in toxicological experiments. Specifically, we extend the
comprehensive infrastructure for dose-response modelling outlined by Ritz and Streibig (2005), but only
for models without random effects, to the case of dose-response mixed-effects models.
We demonstrate its usefulness through two case studies exhibiting different aspects of clustered data: a
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toxicity evaluation in terms of effective doses in a human toxicology study that was replicated six times
over time, and an assessment of potency in a field trial comparing two pesticides using five blocks.
Section 2 introduces nonlinear mixed-effects models in general. In Section 3 the marginalization approach
is derived. A short simulation study is presented in Section 4. Section 5 report results from two case
studies. Finally, we offer a perspective on the developed methodology in Section 6.
2 Hierarchical nonlinear regression models
Following the notation of Davidian and Giltinan (2003), a nonlinear regression model with a single
hierarchical level can be defined in two stages that parametrise the variation within and between specific
curves, respectively.
Stage 1: For the ith individual (i = 1, . . . ,m), we assume the following nonlinear regression model:
yij = f(xij ,βi) + ij (1)
where {yi1, . . . , yini} and {xi1, . . . , xini} denote the vectors of response values and covariate levels, re-
spectively. A population of i different curves is characterized by the nonlinear function f through the
curve-specific effect βi (a q × 1 vector). The within-cluster variation is explained through the residual
error vector i = (i1, . . . , ini), which is assumed to be mean-zero normally distributed with variance-
covariance matrix Λi. In practice this matrix is often structured as σ2Ini or diag(σ21 , . . . , σ2ni).
Stage 2: The between curve variation is captured by splitting the curve-specific effect βi into components
describing the systematic and random variation between curves:
βi = Aiβ +Bibi
where Ai and Bi denote the fixed effects and random effects design matrices, respectively, β denotes the
fixed effects parameters (a p× 1 vector with p ≤ q), and the bi’s denote the curve-specific random effects.
The random effects can be assumed to follow a mean-zero normal distribution with a variance-covariance
matrix denoted G, which usually is simply the unstructured matrix. In what follows we only consider
models with dummy coded design matrices for categorical predictors. These hierarchical models will
still cover many experimental settings used in practice, such as comparison of several treatments in a
dose-response experiment.
3 Quadrature
As already mentioned in the introduction the fixed effect parameters in nonlinear mixed-effects models
usually cannot in general be interpreted as population quantities that are independent of the random
effects, due to the inequality:
f(xij ,Aiβ + 0) 6= E {f(xij ,βi)} = f˜(xj , A˜iβ˜) (2)
where f˜ denotes the unknown marginal mean function and, in particular, β˜ denotes the parameters we
are interested in. In contrast, f denotes the mean function that was specified as part of the model
specification. At this point we should mention that there are a few exceptions such as applications of
nonlinear mixed-effects models with additive random effects on the data scale, meaning that marginal
effects are directly available (e.g., Blankenship et al. (2003), Demidenko (2013, Chap. 6)).
The marginal expectation for a nonlinear mixed-effects model is calculated as follows:
E {f(xij ,βi)} =
∫
· · ·
∫
f{xij , (βi1 + b1, . . . , βip + bp)} Φ(b1, . . . , bp,G) db1 · · · dbp
where Φ() denotes the density function of a p-dimensional normal distribution with mean vector 0 and
variance-covariance matrix G. Note that different nonlinear mixed-effects models will lead to slightly
different definitions of population-average effects. Specifically, this implies that derived marginal effects
are affected by the distributional assumptions made for the random effects.
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Through a change of variables the original random effects may be transformed into a vector of indepen-
dent and identically distributed random effects: bi = Ωui where G = ΩΩT is based on the Cholesky
decomposition and ui ∼ N(0, Ip×p). We may then approximate the integral by the weighted sum:
E {f(xij ,βi)} ≈
N∑
n=1
wnf{xij , (βi1 + ξ1n, . . . , βip + ξpn)}, with wn =
p∏
r=1
wrn, (3)
using numerical Gauss-Hermite quadrature assuming a p × N matrix of nodes Ψ and corresponding
weights wrn, based on independent standard normal distribution functions (Smyth, 1998). The quadra-
ture nodes are transformed by ξ = ΨT Ω̂ to reflect the scales and covariances of the random effects. The
approximation to the integral can be thought of as an average of the individual curves, but instead of
considering a simple mean involving the predicted random effects (the so-called EBLUPs), the average is
based on the estimated multivariate normal distribution of the random effects. Standard errors of derived
parameter estimates are obtained by applying the delta method to Eq. (3) (van der Vaart, 1998, Chap.
5) using a numerically calculated gradient and extending the results by Gerhard et al. (2014).
3.1 Dose-response models
We will focus on the model functions f in Eq. (1) used for the analysis of dose-response data. A number
of different model functions have been proposed in the literature; a short overview and references can
be found in Ritz (2010). However, in practice only a few functions appear to be used routinely. Among
these models the sigmoidal log-logistic model function is by far the one used the most. We define the
five-parameter log-logistic model function as follows:
f(x,β) = β2 +
β3 − β2
(1 + exp[β1{log(x)− log(β4)}])β5 (4)
The commonly used four-parameter version is obtained by setting β5 = 1; this model is routinely applied
in biology, toxicology and weed science (e.g., Price et al. (2012)). One reason for the popularity of this
model is the fact that the model parameters have direct biological interpretations: The parameters β2 and
β3 denote the lower and upper horizontal asymptotes that confine the sigmoidal regression curve. The
parameter β4 denotes the dose resulting in a halfway reduction between the limits β2 and β3 (which corre-
sponds to the ED50 in mixed-effects dose-response models, which are symmetrical increasing/decreasing
around an inflection point, but might be influenced by parameters for asymmetry or hormesis). The pa-
rameter β1 indicates the steepness of the curve in its transition between the two horizontal asymptotes.
The fifth parameter β5 is an asymmetry parameter leading to asymmetry in one or the other tail for
β5 < 1 and β5 > 1, respectively.
Many a time not only the model parameters explicitly included in the model equation are of interest, but
also some derived parameters, like the effective dose resulting in a 100α% (0 < α < 1) reduction relative
to the lower and upper limits (i.e., ED100α) or the ratio of two such effective doses (often referred to as
the relative potency). Inference for derived parameters may be based on using the delta method, which
results in an estimated approximate (asymptotically-based) variance-covariance matrix of the derived
parameters.
For a given fixed effects parameter configurationA0β (e.g., a specific treatment) the effective dose ED100α
is defined as the solution to the following inverse regression problem:
f˜(ED100α,A0β) = αf˜(∞,A0β) + (1− α)f˜(0,A0β)
which may be re-arranged into:
α =
f˜(ED100α,A0β)− f˜(0,A0β)
f˜(∞,A0β)− f˜(0,A0β)
(5)
By definition ED100α values are relative quantities that are defined relative to the lower and upper
limits β2 and β3 in Eq. (4), which corresponds to f˜(0,A0β) and f˜(∞,A0β), respectively. Instead of the
population-level effective dose, a conditional ED100α may also be calculated from the inverse regression of
f(ED100α,A0β+b0), that is conditioning on a given known random effects vector b0, which is often taken
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to be 0. However, both types of effective doses may be derived using the same nonlinear mixed-effects
model.
A related approach used for summarizing dose-response data is the benchmark dose methodology (Piegorsch,
2010). Ritz et al. (2013) proposed an operational definition of the benchmark dose for continuous end-
points, allowing for the incorporation of an a priori specified background level p0 and risk level (benchmark
response: BMR). This definition allows benchmark doses to be estimated as certain effective doses.
3.2 Software implementation
Our approach is implemented in R (R Core Team, 2014). Specifically, we developed the extension package
medrc, which combines the dose-response modelling framework of the package drc, which allows nonlinear
least-squares estimation for one or more dose-response curves through a convenient infrastructure for
model specification and automatic calculation of suitable starting values (Ritz and Streibig, 2005), with
nonlinear mixed-effects estimation using the package nlme (Pinheiro and Bates, 2000).
This framework offers several key features such as having a set of predefined dose-response functions
directly available, providing a unified parametrisation (b: steepness, c,d: lower and upper asymptotes, e:
inflection point location) and an easy-to-use formula interface for specifying the dose-response relationship
and for parametrisation of modelling multiple curves and random effects.
The package medrc is available on GitHub under
https://github.com/daniel-gerhard/medrc.git. An accompanying vignette shows the full function-
ality of the package through additional examples.
4 Simulation Study
The accuracy of the proposed marginalization approach was investigated through simulations and com-
parisons to the marginal estimates obtained by fitting a generalized nonlinear least squares (GNLS)
model assuming a compound-symmetry structure and an ordinary nonlinear least-squares regression
(NLS) model, which entirely ignores the between-cluster variability. Both these marginal models provide
parameter estimates that can be directly interpreted as population parameters, but the information about
cluster effects is lost, i.e., the information is not quantified and therefore not incorporated as a separate
contribution in the estimated standard errors, if appropriate. We also compared the marginalized es-
timates to the conditional estimates obtained directly from the nonlinear mixed effects model fits. As
the conditional parameters have a different interpretation and the marginal parameters are even derived
from different models, it is not expected that these approaches will result in estimates for the marginal-
ized parameter. But it might be possible to characterise the performance of the marginalized estimates
relative to these alternatives.
The simulation scenario was similar to the first case study introduced in the next section: We simulated
from a three-parameter log-logistic model with a random intercept on each of the three parameters and
a dose range from 0.01 to 3 with 10 equally spaced dose levels on the log-scale. The number of clusters
was varied from 2 to 20 to evaluate the precision of the derived parameter estimates as the standard
deviations of the random effects become more precisely determined. The specific configuration of fixed
effects parameters and standard deviations is shown in Table 1. Note the very different magnitudes of
the variation on the three model scales. In order to investigate the influence of different covariance struc-
tures of the random effects and corresponding model misspecification, either a diagonal or unstructured
covariance matrix was assumed for the true and modelled dependence structure.
Table 1: Parameter settings in the simulation study.
Fixed Random effects Correlation of random effects
Parameter effect Std. Dev. Unstructured Diagonal
Steepness (β1) 5 0.5 1 -0.9 0.8 1 0 0
Upper asymptote (β2) 2000 500 -0.9 1 -0.5 0 1 0
ED50 (β4) 0.5 0.1 0.8 -0.5 1 0 0 1
Residuals (ij) 100
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The ‘true’ marginal effective dose parameters were obtained by Monte Carlo integration with 100,000
sampling steps for each parameter settings; this means sampling directly from a multivariate normal
distribution conditioning on the pre-defined, true covariance of the random effects. The accuracy of the
effective doses was evaluated by the median deviation of the estimated parameter relative to the true
marginal parameter as shown in Figure 1. This ‘bias’ has to be cautiously interpreted for the conditional
and marginal approaches, as it shows the deviation to the true marginalized effective dose, which of
course has a different interpretation.
The marginalized estimates had the smallest deviation to the ‘true’ effective dose in every scenario with
a correctly specified correlation structure. The conditional estimate instead remained constant regardless
of the number of clusters. Only when the model was misspecified, assuming a diagonal instead of a true
unstructured covariance matrix of the random effects, the marginalized estimates showed an increased
deviation even at a large number of clusters, but nevertheless this deviation is still in a similar range as
for the marginal estimates.
By increasing the standard deviation of the random effects associated with the parameter ED50 tenfold,
the differences between conditional and marginalized estimated effective doses increased, resulting in an
increasing difference for the conditional estimates (results are shown as Supporting Information). The
differences for the conditional and marginalized estimates were always going in the same direction. For
ED50 and even more so for ED10 the conditional estimates showed a positive difference whereas there
was a negative difference for ED90; this finding is a result of assuming that random effects are associated
with the upper asymptote but not with the lower asymptote, which was fixed at 0.
It is worth noting that overall the two marginal approaches yielded very similar results even though
they involved different assumptions about the correlation structure. By generating the data given a
diagonal random effects structure smaller deviation was observed, as it can be better approximated by
the compound symmetry assumption on the residuals than the unstructured covariance. Moreover, for
ED10 and ED50 the marginal estimates behaved like the marginalized estimates, but for ED90 they
resulted in a deviation in the opposite direction from the conditional and marginalized estimates.
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Figure 1: Simulation result: Median of estimated differences to the true marginalized effective dose
for marginalized, conditional, GNLS, and NLS estimates of ED10, ED50, and ED90 (rows) using either
an unstructured or diagonal variance-covariance matrix for the true and/or modelled random effects
(columns). The true parameter corresponds to the dashed horizontal line at 0.
Figure 2 shows the medians of the estimated standard errors of the effective dose estimates from the
simulation study. The standard errors of the marginalized estimates are comparable to the ones of the
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conditional estimates. The dependence of the marginal estimates on the different scales of the random
effects is apparent: In comparison to the proposed marginalization approach the two marginal models,
which showed very similar behaviour, resulted in estimated standard errors for the estimated ED50 that
were somewhat smaller, but became larger with increasing distance from the inflection point. For the
estimated ED90 (near the lower asymptote that was fixed at zero) the marginal estimates had standard
errors that were larger by a factor 1.5–2, indicating the inability of the marginal models to borrow strength
across different model scales.
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Figure 2: Simulation result: Median of estimated standard errors for marginalized, conditional, GNLS,
and NLS estimates of ED10, ED50, and ED90. An unstructured variance-covariance matrix of the random
effects was used for data generation and modelling.
5 Case Studies
The following case studies were analysed throughout using the R packages drc and medrc as previously
described. Source code to reproduce the results is available in the documentation of the package medrc
(see Section 3.2).
5.1 An example with between-assay variation
Nellemann et al. (2003) carried out experiments to assess the in vitro effects of the fungicide vinclozolin.
The data were obtained using an androgen receptor reporter gene assay, which was repeated six times
(on different days). Each assay resulted in concentration-response data with nine concentrations (in µM)
of the fungicide, and the response measured was chemiluminescence (in luminescence units). The same
nine concentrations were used in all six assays. However, in one assay results were only obtained for eight
concentrations.
A plausible biological assumption was that no signal would be observed for very high fungicide concen-
trations, indicating that a three-parameter log-logistic model with a lower asymptote at 0 ((Eq. (4) with
β2 = 0 and β5 = 1)) would be a realistic model for the data. Assay-specific random effects on each of
the three model parameters, but not on the fixed lower asymptote. This model allowed summarizing the
between-assay variation in terms of a 3× 3 variance-covariance matrix.
A marginal generalized nonlinear least-squares model (GNLS) is used for comparison. Instead of a full
random effects representation of the between-assay variability on the scales of the fixed effects parameters,
a compound-symmetry structure is assumed for the within-assay residuals.
The fitted dose-response curves for the conditional, marginal, and marginalized approaches are shown in
Figure 3 along with the individual assay-specific fitted curves (inserting estimated random effects). In
this case they agreed quite well for high concentration but the marginalized fit is below the conditional fit
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Figure 3: Chemiluminescence observations together with conditional, marginalized, and assay-specific
fitted curves based on a nonlinear mixed-effects regression model assuming a three-parameter log-logistic
regression relationship. The corresponding marginal prediction based on GNLS is also shown.
and slightly below the marginal fit for low concentrations where the response is more variable. Estimated
effective doses are shown in Table 2. For large concentrations (> ED50) the standard errors were smaller
for the marginalized approach than for the marginal and only slightly larger than for the conditional
approach, indicating that the gain in precision achieved using a nonlinear mixed-effects model is retained
through marginalization. For the highest ED levels the standard errors in the marginal approach were
twice as large compared to the conditional and marginalized approaches. This is presumably the result
of modelling the within-assay correlation on the scale of the residuals, independent of the difference in
scales of the two asymptotes.
Table 2: Effective dose estimates for the vinclozolin study obtained from conditional, marginal (GNLS),
and marginalized models.
Conditional Marginalized Marginal (GNLS)
ED Estimate Std.Error Estimate Std.Error Estimate Std.Error
10 0.002 0.001 0.001 0.001 0.001 0.001
25 0.013 0.007 0.010 0.007 0.009 0.004
50 0.101 0.031 0.097 0.039 0.075 0.028
75 0.781 0.141 0.834 0.196 0.655 0.393
90 6.012 1.949 7.638 2.666 5.710 5.394
5.2 An example with between-assay variation and different treatments
Streibig and Dayan (1999) investigated the inhibition of photosynthesis in response to two synthetic
photosystem II inhibitors, the herbicides diuron and bentazon. In an experiment, the effect of oxygen
consumption of thylakoid membranes (chloroplasts) from spinach was measured after incubation with
the synthetic inhibitors. Five assays, three treated with bentazon and two with diuron, were used. For
each assay six increasing herbicide concentrations were applied together with a negative control, using
different dose ranges on a logarithmic scale for the two treatments to encompass the whole dose-response
range based on preliminary experiments.
For the comparison of the two herbicides, dose-response curves were fitted assuming a four-parameter
log-logistic model with a separate set of fixed effects coefficients for each of the two treatments (in total 8
model parameters). Random effects were included for each of the four parameters to model the between-
assay variability in the different model scales. Using the information about the between-assay variability
is especially advantageous as the dose levels for the two herbicides did not cover the same dose range.
The two fixed effect curves were compared by means of relative potencies based on ED10, ED20, ED50,
ED75, ED90 estimates.
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Again, a generalized nonlinear least-squares model (GNLS) is used for comparison, assuming a compound-
symmetry structure of the residuals to reflect the within-assay correlation.
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Figure 4: Observations of oxygen consumption and conditional, marginalized, and assay-specific fitted
curves based on a nonlinear mixed-effects regression model assuming a four-parameter log-logistic regres-
sion relationship for each treatment group. The corresponding marginal prediction based on GNLS is
also shown. For the herbicide treatments their corresponding assay-specific curves are shown, predicting
a response at each assay level.
The fitted mean dose-response curves, derived using the marginal (GNLS) and marginalized approaches,
as well as the assay-specific fitted curves are shown in Figure 4. We can conclude that the marginalized
approach recovers the marginal mean curve very accurately in this case as the fitted mean curves are all
very similar. The estimated relative potencies are shown in Table 3. The conditional and marginalized
estimates were identical and this may be explained by the fact that the between-assay standard deviation
for the slope and ED50 parameters (β1 and β4) effectively were equal to 0; with random effects only on
the scales on the asymptotes of a four-parameter log-logistic model, the fixed effects can be interpreted
as marginal effects. For the marginal model the estimated within-assay correlation coefficient for the
compound symmetry structure was 0.55, but it is not specific to the different scales of the two asymptotes.
Therefore, the confidence intervals were narrower for small ED values and wider for the high ED values.
Table 3: Estimated effective doses and corresponding relative potencies for the spinach data example.
Effective Dose Relative Confidence limits
Model ED Bentazon Diuron potency Lower Upper
10 0.038 0.058 0.652 0.280 1.056
25 0.232 0.108 2.144 1.420 2.911
Conditional 50 1.433 0.203 7.056 5.217 8.980
75 8.832 0.380 23.220 13.112 33.940
90 54.437 0.712 76.415 23.776 133.970
10 0.038 0.058 0.651 0.278 1.058
25 0.232 0.108 2.144 1.421 2.911
Marginalized 50 1.433 0.203 7.056 5.216 8.980
75 8.832 0.380 23.220 13.112 33.940
90 54.437 0.712 76.415 23.776 133.969
10 0.030 0.058 0.513 -0.147 1.278
25 0.207 0.108 1.909 0.584 3.382
Marginal 50 1.445 0.203 7.110 2.385 12.157
75 10.076 0.381 26.478 -6.314 61.692
90 70.286 0.713 98.601 -95.172 318.229
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6 Discussion
We have proposed a novel and flexible marginalization approach for obtaining marginal estimates from
nonlinear mixed-effects models that are routinely used in toxicology and biological science applications.
The approach combines the best of two worlds: interpretable population-level estimates obtained using
models that allow to borrow strength across observations.
For all of the two case studies, the population average interpretation is useful, looking at a representative
sample of subjects characterizing the population of possible subject effects. Basing the interpretation of
a dose effect on a single subject will not be easy to generalise for a range of other future samples from
the subject population; this is different for e.g. medical applications where the benefit of a single patient
might be of foremost interest instead of a general population effect.
We specifically focused on nonlinear mixed-effects dose-response models although the proposed methodol-
ogy is also applicable to other types of nonlinear mixed-effects regression models with normally distributed
random effects.
As an alternative to the Gauss-Hermite quadrature, Monte Carlo integration could be used, sampling
directly from a multivariate normal distribution conditioning on the estimated covariance of the random
effects. But as it is a computationally very demanding approach we do not at present recommend it for
routine analyses.
A limitation of the marginalization approach is the conditioning on estimated standard deviations of the
random effects. This means we ignore the uncertainty involved in using estimated variance components,
potentially leading to underestimation of the uncertainty of our parameter estimates of interest with
consequences for derived p-values and confidence intervals.
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